Knowledge Center
      Article / Jan 01, 2011
    
  What is Special About Inhalation APIs?
      Source:
      
   Drug Development and Delivery, January 2011 
    What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
       / Feb 15, 2024
    
  Drug Design Strategies, Modes of Action, Synthesis and Industrial Challenges Behind Trifluoromethylated New Chemical Entities
Read more
			Scientific Article
		
		
	
			Scientific Article
		
		
	
			Scientific Article